Table 2.

Cutaneous features in anti-SAE + DM patients

CharacteristicAnti-SAE + DM, n = 49
Skin manifestations, yes95.9 (47/49)
 Erythema of the eyelids71.4 (35/49)
 Periorbital oedema44.9 (22/49)
 Gottron’s sign or papules77.5 (38/49)
 Periungual erythema77.5 (38/49)
 Erythema of the upper back (shawl sign)57.1 (28/49)
 Erythema of the upper trunk (V sign)77.5 (38/49)
 Lateral hip erythema (holster sign)34.7 (17/49)
 Panniculitis8.2 (4/49)
 Poikiloderma12.2 (6/49)
 Alopecia8.2 (4/49)
 Calcinosis10.2 (5/49)
 Necrosis12.2 (6/49)
 Cutaneous or mucosal ulceration18.4 (9/49)
Only skin disease at onset, (n = 15)a86.7 (13/15)
RP14.3 (7/49)
CharacteristicAnti-SAE + DM, n = 49
Skin manifestations, yes95.9 (47/49)
 Erythema of the eyelids71.4 (35/49)
 Periorbital oedema44.9 (22/49)
 Gottron’s sign or papules77.5 (38/49)
 Periungual erythema77.5 (38/49)
 Erythema of the upper back (shawl sign)57.1 (28/49)
 Erythema of the upper trunk (V sign)77.5 (38/49)
 Lateral hip erythema (holster sign)34.7 (17/49)
 Panniculitis8.2 (4/49)
 Poikiloderma12.2 (6/49)
 Alopecia8.2 (4/49)
 Calcinosis10.2 (5/49)
 Necrosis12.2 (6/49)
 Cutaneous or mucosal ulceration18.4 (9/49)
Only skin disease at onset, (n = 15)a86.7 (13/15)
RP14.3 (7/49)

Quantitative variables are reported as median and interquartile range (IQR). Qualitative variables are reported as a percentage of the total of the available data. SAE: small ubiquitin like modifier activating enzyme.

a

Indicates the number of patients for whom data was available.

Table 2.

Cutaneous features in anti-SAE + DM patients

CharacteristicAnti-SAE + DM, n = 49
Skin manifestations, yes95.9 (47/49)
 Erythema of the eyelids71.4 (35/49)
 Periorbital oedema44.9 (22/49)
 Gottron’s sign or papules77.5 (38/49)
 Periungual erythema77.5 (38/49)
 Erythema of the upper back (shawl sign)57.1 (28/49)
 Erythema of the upper trunk (V sign)77.5 (38/49)
 Lateral hip erythema (holster sign)34.7 (17/49)
 Panniculitis8.2 (4/49)
 Poikiloderma12.2 (6/49)
 Alopecia8.2 (4/49)
 Calcinosis10.2 (5/49)
 Necrosis12.2 (6/49)
 Cutaneous or mucosal ulceration18.4 (9/49)
Only skin disease at onset, (n = 15)a86.7 (13/15)
RP14.3 (7/49)
CharacteristicAnti-SAE + DM, n = 49
Skin manifestations, yes95.9 (47/49)
 Erythema of the eyelids71.4 (35/49)
 Periorbital oedema44.9 (22/49)
 Gottron’s sign or papules77.5 (38/49)
 Periungual erythema77.5 (38/49)
 Erythema of the upper back (shawl sign)57.1 (28/49)
 Erythema of the upper trunk (V sign)77.5 (38/49)
 Lateral hip erythema (holster sign)34.7 (17/49)
 Panniculitis8.2 (4/49)
 Poikiloderma12.2 (6/49)
 Alopecia8.2 (4/49)
 Calcinosis10.2 (5/49)
 Necrosis12.2 (6/49)
 Cutaneous or mucosal ulceration18.4 (9/49)
Only skin disease at onset, (n = 15)a86.7 (13/15)
RP14.3 (7/49)

Quantitative variables are reported as median and interquartile range (IQR). Qualitative variables are reported as a percentage of the total of the available data. SAE: small ubiquitin like modifier activating enzyme.

a

Indicates the number of patients for whom data was available.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close